Cinnoxicam

Drug Profile

Cinnoxicam

Alternative Names: Piroxicam cinnamate; Sinartrol; SPA S 510

Latest Information Update: 09 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator SPA
  • Developer Bukwang Pharmaceutical; CJ Corporation; SPA
  • Class Nonsteroidal anti-inflammatories; Thiazines
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Rheumatic disorders

Most Recent Events

  • 23 Dec 2002 Cheil Jedang is now called CJ Corporation
  • 15 Feb 2001 Investigation in Rheumatic disorders in Europe (PO)
  • 20 Feb 1997 Launched for Rheumatic disorders in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top